Longer Estrogen Exposure May Protect Against Depression

Share this content:
Longer Estrogen Exposure May Protect Against Depression
Longer Estrogen Exposure May Protect Against Depression

FRIDAY, July 21, 2017 (HealthDay News) -- Women exposed to estrogen for longer periods of time during the reproductive years may have a lower risk of depression, according to a study published online July 17 in Menopause.

Researchers included 1,306 regularly menstruating premenopausal women, aged 42 to 52 years at study entry. The team collected data at baseline and annually for 10 years, focusing on duration of estrogen exposure (menarche to menopausal transition), duration of hormonal birth control use, pregnancies, and lactation.

This researchers found that longer exposure to estrogen was significantly associated with a reduced risk of depression during menopause and for up to 10 years after. The investigators also found that longer use of birth control was associated with a lower risk of depression, but the number of pregnancies or incidence of breastfeeding had no effect.

"This study additionally found a higher risk for depression in those with earlier menopause, fewer menstrual cycles over lifespan, or more frequent hot flashes," JoAnn Pinkerton, M.D., executive director of the North American Menopause Society, said in a society news release. "Women and their providers need to recognize symptoms of depression such as mood changes, loss of pleasure, changes in weight or sleep, fatigue, feeling worthless, being unable to make decisions, or feeling persistently sad, and take appropriate action."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths